On 25 and 26 January the CCHFVaccine kick-off meeting took place at the Paul-Ehrlich-Institut. CCHFVaccine is a multinational and interdisciplinary research project. This consortium will investigate model vaccines against Crimean-Congo haemorrhagic fever for the protection of humans and animals. The Paul-Ehrlich-Institut and the Friedrich-Loeffler-Institut are among the 14 partners involved and will support the project with its regulatory expertise as well as Biosafety Level 4 experimental capacity.
Crimean-Congo haemorrhagic fever is cause by the Crimean-Congo haemorrhagic virus (CCHFV). Ruminants constitute the primary viral reservoir. CCHFV is wide-spread and occurs in various countries in Europe, Asia, the Middle East, and Africa. The virus is transmitted by ticks and the close contact with infected blood or tissue.
Infected animals generally do not show any signs of disease, whereas patients develop flu-like symptoms with fever, muscle and limb ache, as well as neurological and gastrointestinal signs. A subset of those affected develop serious haemorrhagies, and the mortality rate lies around 30 percent. Up to now, neither effective antiviral treatments nor licensed vaccines are available.
The CCHFVaccine Project aims at stepping up efforts to develop and provide vaccines against CCHFV for humans and animals thereby using an One Health approach as already exemplified by the participation of both major German medical and veterinary infectious disease research institutes.
Vaccination of susceptible animals will be pursued to reduce the viral burden, whereas vaccine development for humans primarily aims at the protection of individuals at high risk for exposure. The project consortium is funded with six million € for a period of six years within the scope of the European research and innovation programme "Horizon 2020" (see below).
The CCHFVaccine Consortium is led by Professor Ali Mirazimi at the Swedish Health Agency, the Karolinska Institute, and the Swedish National Veterinary Institute. The Paul-Ehrlich-Institut, which is the competent authority for the authorisation of clinical trials, marketing authorisations, and official batch control in Germany, will provide expert advice in regulatory aspects.
The Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Island of Riems will assess the efficacies of newly developed animal vaccines by challenging cattle in the unique newly commissioned BSL4 high containment laboratory and animal facility. The third German partner involved is the Justus-Liebig University, which is specialised in vaccine design.
Horizon 2020 is the framework programme of the European Union for research and innovation. It promotes research, and as such, aims at developing a knowledge- and innovation-driven society and a competitive economy. At the same time it has the purpose of contributing to sustained development. In addition to the member states of the European Union, various other countries can participate in the Horizon 2020 program.
The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.
Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.
The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).
http://fli.bund.de - FLI Friedrich-Loeffler-Institut
http://cordis.europa.eu/project/rcn/207211_en.html - CORDIS Project Information
https://www.uni-giessen.de/research/research-organizations/eu-projects/cooperati... - CCHFV-Projekt Info of Justus Liebig University Gießen
Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft
Researchers identify how bacterium survives in oxygen-poor environments
22.11.2017 | Columbia University
Researchers discover specific tumor environment that triggers cells to metastasize
22.11.2017 | University of California - San Diego
The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.
Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.
During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....
The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.
Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
22.11.2017 | Medical Engineering
22.11.2017 | Materials Sciences
22.11.2017 | Health and Medicine